Recent Finacing
Recent Raise
Prevacus, spun out of Florida State University, develops nasal-delivered neurosteroid therapeutics (Prevasol) for mild traumatic brain injury, conducting preclinical proof-of-concept, safety and large-animal toxicology studies toward clinical trials.
Focus Areas
Recent Investors
Funding round
Investor